Human Papillomavirus Vaccination and Trends in Cervical Cancer Incidence and Mortality in the US
Menée à partir de données des registres américains des cancers, cette étude analyse l'association entre la mise en oeuvre de la vaccination contre le papillomavirus humain et l'évolution de l'incidence du cancer du col de l'utérus et de la mortalité spécifique sur la période 2001-2017
Human papillomavirus (HPV) is a common sexually transmitted infection and is implicated in most cervical cancer cases. Vaccination against HPV for women and girls aged 11 to 26 years was first recommended in 2006. Randomized clinical trials showed vaccine-driven decreases in precancerous lesions, and observational studies showed vaccine-associated decreases in cervical cancer incidence. However, data demonstrating vaccine-associated changes in cervical cancer mortality are lacking. We aimed to quantify associations between HPV vaccine implementation in the US and changes in cervical cancer incidence and mortality.
JAMA Pediatrics 2021